Corcept Therapeutics | CORT - SCHULD

Aktienkurs
41.57
Täglich Wechseln
0.72 1.76%
Monatlich
22.30%
Jährlich
-41.03%
Q2 Prognose
41.21




SCHULD Veränderung Datum
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Ardelyx USD 207.61M 968K 2025-09
Assertio Holdings USD 38.87M 615K 2023-09
Aurora Cannabis CAD 100.34M 1.29M 2025-09
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Canopy Growth CAD 259.33M 68.47M 2025-09
Corcept Therapeutics USD 6.36M 247K 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Esperion Therapeutics USD 262.92M 1.76M 2024-09
J&J USD 45.8B 4.97B 2025-09
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
Merck USD 41.37B 5.97B 2025-09
Nektar Therapeutics USD 0 0 2022-06
Novartis USD 32.64B 1.37B 2025-06
Novartis USD 32.02B 615M 2025-09
Omeros USD 442.16M 199K 2023-09
Pacira USD 372.19M 4.53M 2025-12
Pfizer USD 60.85B 78M 2025-09
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
TG Therapeutics USD 245.34M 8.38M 2025-09